ScholarIQanswers from OpenAlex
Cytokine Signaling Pathways and Interactions
TopicLeading institutions, researchers & key papers
Cytokine Signaling Pathways and Interactions is a topic indexed in ScholarIQ from OpenAlex.
What is known about Cytokine Signaling Pathways and Interactions?
ScholarIQrecord summary
This cluster of papers focuses on the role of STAT3 in cancer inflammation and immunity, with a particular emphasis on its involvement in cytokine signaling, regulation of the JAK/STAT pathway, modulation of the immune response, and its impact on the tumor microenvironment. The cluster also explores the interplay between STAT3, IL-6, and SOCS proteins in transcriptional control, inflammation, and cancer progression.
How many works does Cytokine Signaling Pathways and Interactions have?
ScholarIQindexed works
Cytokine Signaling Pathways and Interactions has 267 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Cytokine Signaling Pathways and Interactions?
ScholarIQopenalex
The OpenAlex for Cytokine Signaling Pathways and Interactions is on the source record.
What are the most-cited papers on Cytokine Signaling Pathways and Interactions?
ScholarIQmost cited works
HOW CELLS RESPOND TO INTERFERONS
George R. Stark, Ian M. Kerr, Bryan Williams, Robert H. Silverman, Robert D. Schreiber
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok, H. Shaw Warren, Alex G. Cuenca, Michael Mindrinos, Henry V. Baker, Weihong Xu, Daniel R. Richards, Grace P. McDonald-Smith, Hong Gao, Laura Hennessy, Celeste C. Finnerty, Cecilia M. López, Shari Honari, Ernest E. Moore, Joseph P. Minei, Joseph Cuschieri, Paul E. Bankey, Jeffrey L. Johnson, Jason L. Sperry, Avery B. Nathens, Timothy R. Billiar, Michael A. West, Marc G. Jeschke, Matthew B. Klein, Richard L. Gamelli, Nicole S. Gibran, Bernard H. Brownstein, Carol Miller‐Graziano, Steve E. Calvano, Philip H. Mason, J. Perren Cobb, Laurence G. Rahme, Stephen F. Lowry, Ronald V. Maier, Lyle L. Moldawer, David N. Herndon, Ronald W. Davis, Wenzhong Xiao, Ronald G. Tompkins, Amer Abouhamze, Ulysses J. Balis, David Camp, Asit K. De, Brian G. Harbrecht, Douglas L. Hayden, Amit Kaushal, Grant E. O’Keefe, Kenneth T. Kotz, Weijun Qian, David Schoenfeld, Michael B. Shapiro, Geoffrey M. Silver, Richard Smith, John D. Storey, Robert Tibshirani, Mehmet Toner, Julie Wilhelmy, Bram Wispelwey, Wing H. Wong
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer, Maria Ban, Anu Kemppinen, Amie Baker, Sheila Skidmore, Alastair Compston, Garrett Hellenthal, Matti Pirinen, Chris C. A. Spencer, Zhan Su, Colin Freeman, Gavin Band, Amy Strange, Céline Bellenguez, Eleni Giannoulatou, Anna Rautanen, Gil McVean, Peter Donnelly, Nikolaos A. Patsopoulos, P I W de Bakker, Kristin Ardlie, Cristin Aubin, Mark J. Daly, De Jager Pl, David A. Hafler, Susan Pobywajlo, Loukas Moutsianas, Alexander Dilthey, Sarah E. Hunt, Sarah Edkins, Emma Gray, Simon Potter, Matthew Gillman, Rhian Gwilliam, Alagurevathi Jayakumar, Hannah Blackburn, Jennifer Liddle, M. L. Perez, Matthew Waller, Michelle Ricketts, Naomi Hammond, Owen T McCann, Pamela Whittaker, Paul A. Weston, Sara Widaa, Serge Dronov, Suzannah J. Bumpstead, Rathi Ravindrarajah, A Palotie, Panos Deloukas, Cordelia Langford, David R. Booth, Rob N. Heard, Graeme J. Stewart, An Goris, Katleen Clysters, Rita Dobosi, Bénédicte Dubois, Annette Oturai, Finn Sellebjerg, Per Soelberg Sørensen, Helle Bach Søndergaard, Janna Saarela, Virpi Leppä, Anna-Maija Sulonen, Bertrand Fontaine, Isabelle Cournu‐Rebeix, Claire Fontenille, Bernhard Hemmer, Achim Berthele, Dorothea Buck, Sabine Cepok, Muna Hoshi, Juliane Winkelmann, Frauke Zipp, Roland Martinꝉ, Sabine Roesner, Stephen Leslie, SC Hawkins, Sandra D’Alfonso, Laura Bergamaschi, Filippo Martinelli Boneschi, Gıancarlo Comı, Federica Esposito, Vittorio Martinelli, Mariaemma Rodegher, Harbo Hp, Elisabeth Gulowsen Celius, I L Mero, C. Smestad, Åslaug Rudjord Lorentzen, Anne Spurkland, Marcin P. Mycko, Krzysztof Selmaj, E. Tronczyńska, Manuel Comabella, Xavier Montalbán, Ingrid Kockum, Maja Jagodic, Izaura Lima Bomfim
A new protein containing an SH2 domain that inhibits JAK kinases
Takaho A. Endo, Masaaki Masuhara, Masahiro Yokouchi, Ritsu Suzuki, Hiroshi Sakamoto, Kaoru Mitsui, Akira Matsumoto, Shyu Tanimura, Motoaki Ohtsubo, Hiroyuki Misawa, Tadaaki Miyazaki, Nogueira Leonor, Tadatsugu Taniguchi, Takashi Fujita, Yuzuru Kanakura, Seturo Komiya, Akihiko Yoshimura
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo
Raja Atreya, Jonas Mudter, Susetta Finotto, Jürgen Müllberg, Thomas Jostock, Stefan Wirtz, M.M. Schutz, Brigitte Bartsch, Martin Holtmann, Christoph Becker, David Strand, J. Czaja, JF Schlaak, Hans A. Lehr, Frank Autschbach, G. Schürmann, Naoki Nishimoto, Kazuyuki Yoshizaki, Hiroaki Ito, Tadamitsu Kishimoto, Peter R. Galle, Stefan Rose‐John, Markus F. Neurath
Where is Cytokine Signaling Pathways and Interactions research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Cytokine Signaling Pathways and Interactions is open access?
ScholarIQopen access share
40%OPEN ACCESS